Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Campiotti, L"'
Autor:
Renato Bassan, Chiara Pavoni, Pamela Zanghì, Elisabetta Todisco, Nicola Stefano Fracchiolla, Anna Michelato, Leonardo Campiotti, Federico Lussana, Roberta Cavagna, Annamaria Scattolin, Giacomo Gianfaldoni, Chiara Caprioli, Erika Borlenghi, Fabio Ciceri, Ernesta Audisio, Alessandro Rambaldi, Lorella De Paoli, Tamara Intermesoli, Elisabetta Terruzzi, Orietta Spinelli, Ksenija Buklijas, Lara Elidi, Silvia Salmoiraghi, Paola Stefanoni, Paolo Corradini, Daniele Mattei, Irene Cavattoni, Monica Tajana, Elena Oldani
Publikováno v:
Cancers, Vol 12, Iss 2242, p 2242 (2020)
Cancers
Volume 12
Issue 8
Cancers
Volume 12
Issue 8
By way of a Next-Generation Sequencing NGS high throughput approach, we defined the mutational profile in a cohort of 221 normal karyotype acute myeloid leukemia (NK-AML) enrolled into a prospective randomized clinical trial, designed to evaluate an
Autor:
Anna Michelato, Fabio Ciceri, Dario Ferrero, Lorella De Paoli, Renato Bassan, Chiara Caprioli, Paolo Corradini, Silvia Salmoiraghi, Brunangelo Falini, Chiara Cattaneo, Giacomo Gianfaldoni, Agostino Cortelezzi, Federica Delaini, Alessandro Rambaldi, Francesco Mannelli, Leonardo Campiotti, Anna Maria Scattolin, Pamela Zanghì, Erika Borlenghi, Federico Lussana, Massimo Bernardi, Ksenija Buklijas, Daniele Mattei, Elena Oldani, Monica Tajana, Tamara Intermesoli, Roberta Cavagna, Anna De Grassi, Irene Cavattoni, Ernesta Audisio, Elisabetta Terruzzi, Orietta Spinelli, Lara Elidi, Elisabetta Todisco, Chiara Pavoni
Publikováno v:
Haematologica
Secondary acute myeloid leukemia (sAML) after myelodysplastic or myeloproliferative disorders is a high-risk category currently identified by clinical history or specific morphological and cytogenetic abnormalities. However, in the absence of these f
Autor:
Elena Maria Elli, Bruno Martino, Diletta Fontana, Andrea Aroldi, Daniele Ramazzotti, Delphine Rea, Fabio Ciceri, Fabio Stagno, Leonardo Campiotti, Antonio Niro, Monica Fumagalli, Luca Massimino, Rocco Piazza, Carlo Gambacorti-Passerini, Giovanni Caocci
Atypical chronic myeloid leukemia (aCML) is a rare BCR-ABL1 negative clonal disorder, which belongs to the myelodysplastic/myeloproliferative group. This disease is characterized by recurrent somatic mutations in several genes including SETBP1, ASXL1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::133a87e5128f6d4af6bbf845f93489a3
http://hdl.handle.net/10281/271233
http://hdl.handle.net/10281/271233
Autor:
Leonardo Campiotti, Rocco Piazza, Carlo Gambacorti-Passerini, Luigina Guasti, Alessandro Squizzato, Anna Maria Grandi, Matteo B. Suter
Purpose Tyrosine kinase inhibitors (TKIs) are the cornerstones of treatment for patients with chronic myeloid leukaemia (CML). In recent years, several studies were conducted to evaluate the safety of TKIs discontinuation. We performed a systematic r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8765e446a33c5b0cc03c334d729d10c3
http://hdl.handle.net/11383/2062555
http://hdl.handle.net/11383/2062555